QuickRx | Why Hospitals Fear This Bacteria

WHY HOSPITALS FEAR THIS BACTERIA MORE THAN YOU DO

C. Diff Treatment Guide: Dificid (Fidaxomicin) Explained | QuickRx

—

—

Why Do Hospitals Fear C. Diff So Much?

Clostridioides difficile, commonly called C. diff, is one of the most feared bacteria in modern healthcare settings, and for good reason. According to the Centers for Disease Control and Prevention (CDC), C. diff causes approximately 500,000 infections and contributes to 15,000 to 30,000 deaths annually in the United States alone.

However, here is what makes C. diff particularly difficult for healthcare professionals: it is incredibly hard to eliminate. Unlike most bacteria, C. diff forms spores that can survive on surfaces for months. These spores resist standard cleaning products, hand sanitizers, and even some hospital-grade disinfectants. As a result, healthcare facilities wage a constant battle against this persistent pathogen.

Furthermore, the CDC has classified C. diff as an “urgent threat,” the highest threat level assigned to pathogens, highlighting the need for immediate and aggressive action. In fact, C. diff is the most common cause of healthcare-associated diarrhea in developed countries, placing enormous strain on hospital resources and patient outcomes.

The good news is that effective treatments exist, including advanced antibiotics like Dificid (fidaxomicin) that can significantly reduce recurrence rates. If cost is a concern, QuickRx can help eligible patients access Dificid copay assistance and patient assistance programs.

Need Help Affording Fidaxomicin?

917-830-2525

What Is C. Diff and Who Gets It?

Clostridioides difficile (C. diff) is a gram-positive, spore-forming, anaerobic bacterium that causes severe diarrhea and colitis. The bacteria produce toxins, specifically Toxin A (enterotoxin) and Toxin B (cytotoxin), that damage the intestinal lining and cause inflammation.

How Does C. Diff Infection Happen?

C. diff infection typically occurs through a specific chain of events:

1. Antibiotic use disrupts normal gut bacteria: When you take broad-spectrum antibiotics, they kill not only harmful bacteria but also the beneficial microorganisms that normally keep C. diff in check.
2. C. diff spores enter the body: Spores can be ingested through contact with contaminated surfaces, hands, or objects.
3. Bacteria multiply and produce toxins: With the normal gut microbiome disrupted, C. diff can flourish and produce tissue-damaging toxins.
4. Symptoms develop: Toxins cause inflammation, leading to watery diarrhea and other symptoms.

Who Is at Risk for C. Diff?

While anyone can develop C. diff, certain factors significantly increase your risk:

• Antibiotic use: The single most important risk factor, particularly fluoroquinolones, clindamycin, cephalosporins, and penicillins
• Age over 65: More than 80 percent of C. diff deaths occur in people 65 years and older
• Recent hospitalization: Healthcare settings have higher concentrations of C. diff spores
• Long-term care residence: Nursing homes and assisted living facilities see elevated rates
• Weakened immune system: Immunocompromised patients are more susceptible
• Previous C. diff infection: Prior infection increases risk of recurrence
• Proton pump inhibitor (PPI) use: Acid-reducing medications may increase susceptibility
• Gastrointestinal surgery or procedures: Recent GI interventions raise risk

The Rise of Community-Acquired C. Diff

C. diff is no longer just a hospital problem. According to research published in Infection Control & Hospital Epidemiology, community-acquired C. diff cases have increased significantly over the past decade. These patients tend to be younger and may have fewer traditional risk factors, making diagnosis more challenging.

—

What Are the Symptoms and Complications of C. Diff?

C. diff symptoms can range from mild diarrhea to life-threatening colitis. Understanding the spectrum of symptoms helps with early detection and treatment.

Common Symptoms of C. Diff Infection

• Watery diarrhea: Often 10 to 15 or more episodes per day
• Abdominal cramping and pain: Can range from mild to severe
• Fever: Usually low-grade but can be high in severe cases
• Nausea and loss of appetite: May lead to dehydration and weight loss
• Blood or pus in stool: Indicates more severe inflammation
• Dehydration: Due to fluid loss from diarrhea

Severe and Life-Threatening Complications

Without proper treatment, C. diff can progress to serious complications:

• Pseudomembranous colitis: Severe inflammation with yellow-white plaques on the colon lining
• Toxic megacolon: Dangerous dilation of the colon that can lead to perforation
• Bowel perforation: A hole in the intestinal wall requiring emergency surgery
• Sepsis: Life-threatening infection spreading throughout the body
• Death: Severe C. diff carries a mortality rate of 5 to 10 percent or higher

—

How Is C. Diff Treated?

Treatment for C. diff has evolved significantly, with current guidelines recommending fidaxomicin (Dificid) as the preferred first-line therapy for most patients.

First-Line Treatment Options

According to the Infectious Diseases Society of America (IDSA) 2021 guidelines update:

• Fidaxomicin (Dificid): 200 mg twice daily for 10 days, listed as preferred
• Vancomycin: 125 mg four times daily for 10 days, listed as an alternative

The 2021 guideline update specifically recommends fidaxomicin over vancomycin for initial and recurrent episodes of non-fulminant C. diff infection. This recommendation is based on fidaxomicin’s ability to prevent recurrence.

Treatment for Recurrent C. Diff

Recurrent C. diff, defined as symptom return within 8 weeks of completing treatment, affects 15 to 35 percent of patients. For these patients, treatment options include:

• Fidaxomicin: Standard or extended-pulse regimen
• Vancomycin taper and pulse regimen: Gradually decreasing doses over weeks
• Bezlotoxumab (Zinplava): Monoclonal antibody given with antibiotics to prevent recurrence
• Fecal microbiota transplantation (FMT): For multiple recurrences

—

What Is Dificid (Fidaxomicin) and Why Is It Preferred?

Dificid (fidaxomicin) is a narrow-spectrum macrocyclic antibiotic specifically designed to treat C. diff infections while preserving the normal gut microbiome.

How Does Dificid Work?

Fidaxomicin works by inhibiting bacterial RNA polymerase, which stops C. diff from producing proteins essential for survival and reproduction. What makes it unique is its narrow spectrum of activity, which targets C. diff while leaving most beneficial gut bacteria intact.

This is important because disruption of the gut microbiome is what allows C. diff to flourish in the first place. By preserving healthy bacteria, fidaxomicin helps restore the body’s natural defenses against C. diff recurrence.

Dificid Dosing and Administration

• Standard dose: 200 mg twice daily for 10 days
• Administration: Take with or without food
• Form: Oral tablets (200 mg) or oral suspension for pediatric patients
• FDA approval: Approved for adults and children 6 months and older

Common Side Effects of Dificid

Fidaxomicin is generally well-tolerated. Common side effects include nausea, vomiting, abdominal pain, anemia, and rarely gastrointestinal bleeding. Most side effects are mild and resolve after completing treatment.

Need Help Affording Fidaxomicin?

917-830-2525

Is Fidaxomicin Better Than Vancomycin for C. Diff?

Current IDSA and SHEA guidelines list fidaxomicin (Dificid) as the preferred first-line treatment over vancomycin for C. diff, mainly because it produces lower recurrence rates. In clinical trials, both antibiotics achieved comparable initial cure rates of 88 to 92 percent, but fidaxomicin was associated with roughly 31 percent lower risk of recurrence. Fidaxomicin is also dosed twice daily versus four times daily for oral vancomycin, and its narrow spectrum causes less disruption to the gut microbiome. According to research in the New England Journal of Medicine, recurrence rates were 13 to 16 percent with fidaxomicin versus 24 to 25 percent with vancomycin. A systematic review in Pharmacotherapy confirmed this advantage across multiple patient subgroups.

Is There a Generic for Dificid, and When Did It Launch?

Yes. Generic fidaxomicin 200 mg tablets are available in the United States and contain the same active ingredient as brand-name Dificid, meeting identical FDA standards for quality, strength, purity, and stability. The 40 mg/mL oral suspension formulation remains brand-only, which may matter for pediatric patients or adults who cannot swallow tablets. Generic fidaxomicin may carry a lower cash price and a lower insurance copay tier than brand Dificid. QuickRx can help you compare brand and generic options to find the lowest out-of-pocket path for your situation.

How Much Does Dificid Cost Without Insurance?

Without insurance, a standard 10-day course of brand Dificid can cost several thousand dollars, though generic fidaxomicin 200 mg tablets are typically lower. Actual cash price varies by pharmacy and by whether you use the brand or generic. Very few patients pay the full list price, because commercial insurance, manufacturer copay assistance, patient assistance programs for uninsured patients, and independent foundation grants for Medicare patients can all reduce the real cost, sometimes to $0 for eligible patients. For current cash and discount pricing you can reference third-party tools such as GoodRx or Drugs.com. To find out what you would actually pay with assistance, QuickRx can review your coverage at no charge.

What Foods and Drugs Should You Avoid With Dificid?

Dificid (fidaxomicin) has no specific food restrictions and may be taken with or without food, but it does have several drug interactions worth reviewing with your pharmacist. Because fidaxomicin works almost entirely inside the gut with minimal absorption into the bloodstream, dietary limits are not required. Notable drug interactions include live vaccines such as the cholera and live-attenuated typhoid (Ty21a) vaccines, oral or rectal live fecal microbiota products, mycophenolate, mizolastine, Bacillus clausii probiotics, and sodium picosulfate bowel preparations. Always review your full medication and supplement list with your pharmacist before starting Dificid.

Need Help Affording Fidaxomicin?

Start Your Application

—

How Can You Prevent C. Diff?

Prevention is critical, especially for those at high risk or recovering from a previous C. diff infection.

Smart Antibiotic Use

• Only take antibiotics when necessary: Do not pressure your doctor for antibiotics for viral infections
• Complete your prescribed course: Do not stop early, even if you feel better
• Never share antibiotics: Medications should only be taken by the person they are prescribed for
• Discuss alternatives: Ask your doctor about narrower-spectrum antibiotics when appropriate

Hygiene Practices

• Wash hands with soap and water: Hand sanitizers do NOT kill C. diff spores; only soap and friction remove them
• Clean surfaces properly: Use bleach-based cleaners in healthcare settings and if someone at home has C. diff
• Practice good bathroom hygiene: Especially important if you or a household member has C. diff

Healthcare Setting Precautions

• Ask about infection rates: Hospitals track and report C. diff rates
• Ensure healthcare workers wash hands: It is okay to ask if they have washed before examining you
• Limit unnecessary hospital stays: Shorter stays mean less exposure

—

When Should You Call Your Doctor?

Contact your healthcare provider promptly if you experience:

• New or worsening diarrhea (3 or more loose stools per day)
• Diarrhea while taking or within 8 weeks of completing antibiotics
• Abdominal pain or cramping
• Fever above 100.4°F (38°C)
• Blood or mucus in your stool
• Signs of dehydration (excessive thirst, decreased urination, dizziness)
• Return of symptoms after completing C. diff treatment

“Early detection and treatment of C. diff is crucial for preventing complications and recurrence. If you are experiencing symptoms, especially after recent antibiotic use or hospitalization, do not wait, contact your healthcare provider immediately.”
Julia Kravtsova, PharmD, Head Patient Navigator, QuickRx Specialty Pharmacy

—

Frequently Asked Questions About C. Diff and Dificid

What is Dificid (fidaxomicin) used for?

Dificid (fidaxomicin) is an FDA-approved antibiotic specifically used to treat Clostridioides difficile (C. diff) infections in adults and children 6 months and older. It is a narrow-spectrum antibiotic that targets C. diff while preserving beneficial gut bacteria.

How long does it take for Dificid to work?

Most patients notice improvement in diarrhea within 2 to 3 days of starting Dificid. However, it is essential to complete the full 10-day course of treatment even if symptoms improve earlier, to help prevent recurrence.

Can C. diff come back after Dificid treatment?

Yes, C. diff can recur, but fidaxomicin has lower recurrence rates (13 to 16 percent) compared to vancomycin (24 to 25 percent). If C. diff returns, contact your healthcare provider for evaluation and treatment options.

Is C. diff contagious?

Yes, C. diff can spread from person to person through contact with contaminated surfaces or hands. The spores can survive for months on surfaces. However, most healthy people who come into contact with C. diff spores will not develop an infection; it primarily affects those with disrupted gut bacteria from antibiotic use.

Can I take probiotics with Dificid?

Some healthcare providers recommend probiotics during or after C. diff treatment to help restore healthy gut bacteria. However, evidence on their effectiveness is mixed. Always consult your healthcare provider before adding probiotics to your regimen.

How is C. diff diagnosed?

C. diff is typically diagnosed through stool tests that detect C. diff toxins or genetic material. Your healthcare provider may order a toxin assay (EIA), a nucleic acid amplification test (NAAT/PCR), or both. Diagnosis requires both a positive test and symptoms; the presence of C. diff bacteria alone does not confirm infection.

—

How QuickRx Helps Patients Access Dificid

Getting help with Dificid costs is simple with QuickRx Specialty Pharmacy.

Step 1: Contact Us

Call (917) 830-2525 or complete our online copay assistance form.

Step 2: We Verify Your Benefits

Our team contacts your insurance to verify coverage and identifies all assistance programs you may qualify for.

Step 3: Enrollment Support

We complete applications for manufacturer copay cards, patient assistance programs, or foundation grants, whichever applies to your situation.

Step 4: Prescription Coordination

We work with your healthcare provider to obtain your prescription and handle prior authorization if required.

Step 5: Free Delivery

Your medication is delivered directly to your door with free nationwide shipping. You will have ongoing support from our team throughout your treatment.

“At QuickRx, we believe no one should have to delay life-saving C. diff treatment because of cost. Our team handles the complex paperwork so you can focus on getting better.”
Julia Kravtsova, PharmD, Head Patient Navigator

—

Need Help Affording Fidaxomicin? Fill out this form and a QuickRx patient navigator will reach out.

Start Your Application

—

Medical References & Sources

1. Centers for Disease Control and Prevention. Clostridioides difficile Infection (CDI) Surveillance. Accessed January 2026.
2. Guh AY, et al. Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes. N Engl J Med. 2020;382(14):1320-1330.
3. Louie TJ, et al. Fidaxomicin versus Vancomycin for Clostridium difficile Infection. N Engl J Med. 2011;364(5):422-431.
4. Johnson S, et al. Clinical Practice Guideline by the IDSA and SHEA: 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021.
5. Liao CH, et al. Path of least recurrence: A systematic review and meta-analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection. Pharmacotherapy. 2022.
6. MedlinePlus. Fidaxomicin Drug Information. Accessed January 2026.
7. Mayo Clinic. C. difficile infection – Symptoms and causes. Accessed January 2026.

—

HIPAA Notice: QuickRx Specialty Pharmacy protects patient privacy in accordance with HIPAA regulations. Any information you provide will be handled confidentially. For our complete privacy policy, visit our website or contact us directly.

—

Last Updated: July 2026

Written By: Paola Larrabure, Pharma Content Manager, QuickRx Specialty Pharmacy

Reviewed By: Julia Kravtsova, PharmD, Head Patient Navigator, QuickRx Specialty Pharmacy